Regeneron Pharmaceuticals Modification Agreements

22 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment Agreement to License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Bayer Healthcare LLC (May 7, 2012)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2025
Amendment No. 3 to Master Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2024
Amendment No. 2 to Master Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2024
Amendment No. 1 to Master Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2023
Modification No. 06 to Project Agreement No. 01 between Regeneron Pharmaceuticals, Inc. and Advanced Technology International (MCDC)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 04 to Project Agreement No. 01 between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 03 to Project Agreement No. 01 between Regeneron Pharmaceuticals, Inc. and Advanced Technology International for Large-Scale Manufacturing of COVID-19 Antibodies
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 02 to MCDC Base Agreement Between Regeneron Pharmaceuticals, Inc. and ATI
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 5 to Project Agreement No. 01 (MCDC2008-005) between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 05 to Project Agreement No. 01 (MCDC2008-005) between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 01 to MCDC Base Agreement Between Regeneron Pharmaceuticals, Inc. and ATI
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 02 to Project Agreement No. 01 between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Modification No. 01 to Project Agreement No. 01 (MCDC2008-005) between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Amendment to Investor Agreement between Regeneron Pharmaceuticals, Inc. and Sanofi (May 25, 2020)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Second Amendment Agreement to License and Collaboration Agreement between Regeneron Ireland DAC and Bayer Healthcare LLC
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Letter Agreement Regarding PDGF Products Between Regeneron Pharmaceuticals, Inc. and Aventis Pharmaceuticals Inc. (Sanofi)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
Amendment Agreement to License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Bayer Healthcare LLC (May 7, 2012)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2012
Amendment and Agreement between Regeneron Pharmaceuticals, Inc. and The Procter & Gamble Company (June 30, 2005)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
Amendment No. 4 to Manufacturing Agreement between Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
Amendment No. 3 to Manufacturing Agreement between Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
Amendment No. 2 to Manufacturing Agreement between Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
Amendment No. 1 to Manufacturing Agreement between Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2005